CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 106 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $39 | -81.2% | 91 | -71.3% | 0.00% | – |
| Q4 2022 | $208 | -99.9% | 317 | 0.0% | 0.00% | – |
| Q3 2022 | $273,000 | +56.9% | 317 | 0.0% | 0.00% | – |
| Q2 2022 | $174,000 | -45.5% | 317 | +10.5% | 0.00% | – |
| Q1 2022 | $319,000 | -35.4% | 287 | 0.0% | 0.00% | – |
| Q4 2021 | $494,000 | -43.9% | 287 | 0.0% | 0.00% | – |
| Q3 2021 | $881,000 | 0.0% | 287 | +27.0% | 0.00% | – |
| Q2 2021 | $881,000 | -96.1% | 226 | -97.2% | 0.00% | – |
| Q1 2021 | $22,702,000 | +66.2% | 8,137 | +82.3% | 0.00% | – |
| Q4 2020 | $13,660,000 | -57.0% | 4,464 | -14.6% | 0.00% | – |
| Q3 2020 | $31,792,000 | +311.9% | 5,229 | +300.4% | 0.00% | – |
| Q2 2020 | $7,718,000 | -60.9% | 1,306 | -82.4% | 0.00% | – |
| Q1 2020 | $19,716,000 | +100.9% | 7,440 | +106.2% | 0.00% | – |
| Q4 2019 | $9,816,000 | -71.8% | 3,609 | +25.6% | 0.00% | – |
| Q3 2019 | $34,833,000 | +67.3% | 2,874 | +58.1% | 0.00% | – |
| Q2 2019 | $20,816,000 | – | 1,818 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 325,000 | $861,000 | 4.66% |
| MFN Partners Management, LP | 2,427,677 | $6,433,000 | 0.85% |
| EcoR1 Capital, LLC | 2,742,276 | $7,267,000 | 0.76% |
| Slate Path Capital LP | 1,196,063 | $3,170,000 | 0.24% |
| Eversept Partners, LP | 337,145 | $893,434 | 0.22% |
| Artal Group S.A. | 1,861,584 | $4,933,000 | 0.21% |
| Alambic Investment Management, L.P. | 21,265 | $56,000 | 0.14% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 198,106 | $525,000 | 0.12% |
| SPHERA FUNDS MANAGEMENT LTD. | 124,976 | $331,000 | 0.04% |
| Broderick Brian C | 32,175 | $86,000 | 0.03% |